• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

10,890
10,260
8,516
7,356
6,805

COUNTRY

4,393
2,899
2,477
1,519
1,478

CATEGORIES

  • 2,332
    • 199
    • 2,158
    • 68
    • 240
    • 34
    • 190
    • 191
  • 397
    • 93
    • 69
    • 121
  • 10,216
    • 861
    • 635
      • 200
      • 159
      • 219
      • 247
      • 636
    • 847
    • 47
    • 118
    • 188
  • 3,336
  • 133
  • 923
  • 989
  • 905
  • 1,405
  • 278

PRICE

16,889
21,882
28,520
43,761

PUBLISHED

1,630
4,238
12,725
43,761

PRODUCT TYPE

30,415
8,189
3,964
392
225
209
202
149
8
3
3
1
1

Healthcare and Medical Devices

(43,761 Products)

Healthcare consumes over 10% of GDP in most developed countries, and it has huge potential to grow in emerging economies such as India and China. But is the industry really in good health?

You can check the state of health of this multibillion dollar industry in the publications listed under Research and Markets’ Healthcare and Medical Devices category: our reports, books, and subscriptions will allow you to tap into the latest quantitative and qualitative data on every aspect of this dynamic and lucrative sector. They cover all the key sectors of healthcare including diagnostics (in vitro, imaging, screening, etc.); testing (glucose, cholesterol, infectious disease, etc.); hospitals (dialysis, equipment, information systems, etc.); medical devices (cardiovascular, orthopaedic, stents); and associated areas like the dental and veterinary industries.

Also covered comprehensively are regional, national and international profiles of healthcare systems - including public, private and partnerships – across the world, and associated issues such as obesity, population health, health insurance, etc.

Hundreds of players that are shaping today’s market are featured in our publications, including world's giants such as Johnson & Johnson, GE Healthcare, Covidien (formerly Tyco), Siemens Healthcare, Medtronic, and many more.

If you are looking for reports on Health Insurance please browse the relevant sub-category under Banking and Financial Services. Show Less
Read more

2014 Granite Transformations Franchise Disclosure Document (FDD) 2014 Granite Transformations Franchise Disclosure Document (FDD) - Product Thumbnail Image

2014 Granite Transformations Franchise Disclosure Document (FDD)

This PDF Report includes a complete copy of the Franchise Disclosure Document (FDD) for the Rocksolid Granit (USA), Inc. franchise brand. Disclosure documents are valuable to attorneys, franchisees...

September 2014

Introduction to Community and Public Health

Learn the basics of the five core areas of community and public health Introduction to Community and Public Health covers the basics in each area of community and public health as identified by the...

September 2014

Chesley's Hypertensive Disorders in Pregnancy. Edition No. 4

Chesley's Hypertensive Disorders in Pregnancy continues its tradition as one of the beacons to guide the field of preeclampsia research, recognized for its uniqueness and utility. Hypertensive disorders...

September 2014

Orthopaedic and Trauma Nursing. An Evidence-based Approach to Musculoskeletal Care

Orthopaedic and Trauma Nursing provides practitioners working in orthopaedic and musculoskeletal trauma settings with the essential evidence, guidance and knowledge required to underpin effective practice....

September 2014

Cognitive Behavioral Group Therapy. Challenges and Opportunities

With coverage of the latest theory and research, this is a complete guide to implementing cognitive behavioral group therapy for practitioners and trainees in a range of mental health disciplines. ...

September 2014
FROM

Fundamentals of Health Promotion for Nurses. 2nd Edition

Fundamentals of Health Promotion for Nurses is a concise, accessible introduction to health promotion and public health for pre-registration nursing students and newly qualified nurses. Promoting the...

September 2014

Mindfulness and Schema Therapy. A Practical Guide

Mindfulness and Schema Therapy presents an eight-session + two follow up sessions protocol for schema mindfulness for therapists and their patients. - Represents the first book to integrate the...

September 2014
FROM

Interpreting Lung Function Tests. A Step-by Step Guide

Lung function assessment is the central pillar of modern respiratory diagnosis, providing invaluable information to assist in clinical decision making and management strategies.Interpreting Lung Function...

September 2014
2014 Downsize Fitness Franchise Disclosure Document (FDD) 2014 Downsize Fitness Franchise Disclosure Document (FDD) - Product Thumbnail Image

2014 Downsize Fitness Franchise Disclosure Document (FDD)

This PDF Report includes a complete copy of the Franchise Disclosure Document (FDD) for the DSF Franchising LLC franchise brand. Disclosure documents are valuable to attorneys, franchisees and prospective...

September 2014

The Mitochondrion in Aging and Disease, Vol 127

Mitochondria, the "power plants" of eukaryotic cells, are best known for the generation of adenosine triphosphate (ATP), the universal cellular "energy currency" of the cell, and the synthesis of different...

September 2014

Italy Pharmaceuticals and Healthcare Report Q4 2014

BMI View: The drop in public pharmaceutical expenditure in Italy in 2013 to a level below that of spending a decade ago does not bode well for prescription drugmakers, patients and pharmacies in the...

September 2014

New Zealand Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Limited pharmaceutical reimbursement in New Zealand will remain a key issue for innovative pharmaceutical firms as the country seeks to maintain tight control over pharmaceutical spending....

September 2014

Turkey Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Despite a challenging pricing and reimbursement situation compounded by currency uncertainty, BMI still believes the Turkish pharmaceutical market is attractive in the long term as higher...

September 2014

Singapore Pharmaceuticals and Healthcare Report Q4 2014

BMI View: While Singapore's small population will limit the pharmaceutical market's overall growth potential, the government's commitment to healthcare as well as the ageing population will boost consumption...

September 2014

Sweden Pharmaceuticals and Healthcare Report Q4 2014

BMI View: As Sweden's population grows older and demands for healthcare provision increase, the government is facing a concerning scenario of rapidly increasing expenditure on medical services. Restricting...

September 2014

The Rat Nervous System. Edition No. 4

The previous editions of The Rat Nervous System were indispensable guides for those working on the rat and mouse as experimental models. The fourth edition enhances this tradition, providing the latest...

September 2014

Nigeria Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Nigeria's economy is largely dependent on its Oil and Gas sector. The likelihood of further divestments by international oil companies from the sector creates a downside risk to increasing...

September 2014

Cameroon Pharmaceuticals and Healthcare Report Q4 2014

BMI View: A combination of the adoption of different mobile health innovations, health-targeted foreign aid inflows and sustained infrastructure investment will continue to create opportunities for...

September 2014

Colombia Pharmaceuticals and Healthcare Report Q4 2014

BMI View: President Juan Manuel Santos' re-election in June has given him a strong mandate to continue the process of healthcare reform in Colombia. Although the Santos administration has been successful...

September 2014

Vital Signs - Healthcare News - The Analyst's Perspecive - 2014 Issue 8

This issue of Vital Signs, released on September 3, 2014, discusses Thermo Fisher Scientific's divestment of laboratory equipment company Cole-Parmer to GTCR, the increasing use of large animal biotechnology...

September 2014
FROM
Loading Indicator

Our Clients

AB Sciex Eli Lilly and Company B. Braun Melsungen AG Astellas Pharma, Inc. Hologic Corporation Merck & Co., Inc.